SELENOS and glioblastoma: Since, according to previously obtained data [5,6,7,8,10], mRNA expression of the SELENOM and SELENOT genes is quite high in the brain, we chose human glioblastoma cells (line A-172) to achieve the most pronounced knockdown of these selenoproteins.